Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 11 | $1,324,850 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 21 Feb 2025 18:10 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 18 Feb 2025 | Sale | 4,370 | 11.963 | 52,278 | D |
| 19 Nov 2024 16:30 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 18 Nov 2024 | Sale | 2,602 | 13.2102 | 34,373 | D |
| 19 Aug 2024 18:07 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 16 Aug 2024 | Sale | 2,633 | 13.9991 | 36,860 | D |
| 17 May 2024 18:15 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 16 May 2024 | Sale | 2,675 | 16.0787 | 43,011 | D |
| 03 May 2024 18:44 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 03 May 2024 | Sale | 8,078 | 17.8527 | 144,214 | D |
| 03 May 2024 18:44 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 02 May 2024 | Sale | 200 | 17.8955 | 3,579 | D |
| 03 May 2024 18:44 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 01 May 2024 | Sale | 52,183 | 17.887 | 933,397 | D |
| 20 Feb 2024 18:36 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 16 Feb 2024 | Sale | 2,666 | 15.2481 | 40,651 | D |
| 17 Nov 2023 18:33 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO and Secretary | 16 Nov 2023 | Sale | 956 | 11.69 | 11,176 | D |
| 17 Aug 2023 19:02 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO and Secretary | 17 Aug 2023 | Sale | 922 | 13.86 | 12,779 | D |
| 17 May 2023 18:36 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO and Secretary | 16 May 2023 | Sale | 955 | 13.1223 | 12,532 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)